Heart rate control in septic shock-"every journey begins with a first step" (Confucius)

. 2025 Jan ; 51 (1) : 222-223. [epub] 20241111

Status In-Process Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu dopisy

Perzistentní odkaz   https://www.medvik.cz/link/pmid39527120
Odkazy

PubMed 39527120
DOI 10.1007/s00134-024-07721-z
PII: 10.1007/s00134-024-07721-z
Knihovny.cz E-zdroje

Zobrazit více v PubMed

Rehberg S, Frank S, Černy V et al (2024) Landiolol for heart rate control in patients with septic shock and persistent techycardia (LANDI-SEP). Intensive Care Med 50(10):1622–1634. https://doi.org/10.1007/s00134-024-07587-1 PubMed DOI PMC

Vazgiourakis V, Mantzarlis K, Makris D (2024) Landiolol in patients with septic shock. Intensive Care Med. https://doi.org/10.1007/s00134-024-07706-y

Whitehouse T, Hossain A, Perkins GD (2023) Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA 330:1641–1652 PubMed DOI PMC

Unger M, Morelli A, Singer M et al (2018) Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial. Trials 19(1):637 PubMed DOI PMC

Morelli A, Romano SM, Sanfilippo F et al (2020) Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction. Br J Anaesth 125:1018–1024 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...